Baxter Holding B.V.
5 products tracked · names used in filings: Baxter Holding B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Eribulin Baxter eribulin | Authorised | 2024-06-27 |
| 🇪🇺 | Pemetrexed Baxter pemetrexed | Withdrawn | 2022-12-09 |
| 🇪🇺 | Celdoxome pegylated liposomal doxorubicin hydrochloride | Lapsed | 2022-09-15 |
| 🇪🇺 | Inpremzia insulin human (rDNA) | Withdrawn | 2022-04-25 |
| 🇪🇺 | Caelyx pegylated liposomal doxorubicin | Authorised | 1996-06-20 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.